BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9718089)

  • 1. Inhibition of methoxyresorufin demethylase activity by flavonoids in human liver microsomes.
    Zhai S; Dai R; Wei X; Friedman FK; Vestal RE
    Life Sci; 1998; 63(8):PL119-23. PubMed ID: 9718089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes.
    Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF
    Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids.
    Zhai S; Dai R; Friedman FK; Vestal RE
    Drug Metab Dispos; 1998 Oct; 26(10):989-92. PubMed ID: 9763404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids.
    Tsyrlov IB; Mikhailenko VM; Gelboin HV
    Biochim Biophys Acta; 1994 Apr; 1205(2):325-35. PubMed ID: 8155716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human cytochrome P450 1A2 by flavones: a molecular modeling study.
    Dai R; Zhai S; Wei X; Pincus MR; Vestal RE; Friedman FK
    J Protein Chem; 1998 Oct; 17(7):643-50. PubMed ID: 9853678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation by phytochemicals of cytochrome P450-linked enzyme activity.
    Teel RW; Huynh H
    Cancer Lett; 1998 Nov; 133(2):135-41. PubMed ID: 10072162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bioflavonoids on hepatic P450 activities.
    Obermeier MT; White RE; Yang CS
    Xenobiotica; 1995 Jun; 25(6):575-84. PubMed ID: 7483658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
    Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
    Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of citrus flavonoids on the mutagenicity of heterocyclic amines and on cytochrome P450 1A2 activity.
    Bear WL; Teel RW
    Anticancer Res; 2000; 20(5B):3609-14. PubMed ID: 11131669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apiaceous vegetable constituents inhibit human cytochrome P-450 1A2 (hCYP1A2) activity and hCYP1A2-mediated mutagenicity of aflatoxin B1.
    Peterson S; Lampe JW; Bammler TK; Gross-Steinmeyer K; Eaton DL
    Food Chem Toxicol; 2006 Sep; 44(9):1474-84. PubMed ID: 16762476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of nonhydroxylated flavonoids as inducers of cytochrome P450 1A and 2B isozymes in rat liver.
    Canivenc-Lavier MC; Bentejac M; Miller ML; Leclerc J; Siess MH; Latruffe N; Suschetet M
    Toxicol Appl Pharmacol; 1996 Feb; 136(2):348-53. PubMed ID: 8619243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate.
    Smith TJ; Guo Z; Guengerich FP; Yang CS
    Carcinogenesis; 1996 Apr; 17(4):809-13. PubMed ID: 8625495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azide inhibits human cytochrome P -4502E1, 1A2, and 3A4.
    Salmela KS; Tsyrlov IB; Lieber CS
    Alcohol Clin Exp Res; 2001 Feb; 25(2):253-60. PubMed ID: 11236840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure-activity relationships of flavonoids as inhibitors of cytochrome P-450 enzymes in rat liver microsomes and the mutagenicity of 2-amino-3-methyl-imidazo[4,5-f]quinoline.
    Lee H; Wang HW; Su HY; Hao NJ
    Mutagenesis; 1994 Mar; 9(2):101-6. PubMed ID: 8201941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of murine hepatic cytochrome P450 activities by natural and synthetic phenolic compounds.
    Baer-Dubowska W; Szaefer H; Krajka-Kuzniak V
    Xenobiotica; 1998 Aug; 28(8):735-43. PubMed ID: 9741952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ethoxy- and pentoxy-resorufin dealkylases of rat liver by flavones and flavonols: structure-activity relationship.
    Siess MH; Pennec A; Gaydou E
    Eur J Drug Metab Pharmacokinet; 1989; 14(3):235-9. PubMed ID: 2612520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ethoxyresorufin deethylase activity by natural flavonoids in human and rat liver microsomes.
    Siess MH; Le Bon AM; Suschetet M; Rat P
    Food Addit Contam; 1990; 7 Suppl 1():S178-81. PubMed ID: 2262030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9.
    Otake Y; Walle T
    Drug Metab Dispos; 2002 Feb; 30(2):103-5. PubMed ID: 11792676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiton of cytochrome P450 isoenzymes and P-gp activity by multiple extracts of Huang-Lian-Jie-Du decoction.
    Wang Y; Jiang YM; Wang YT; Kang JW; Yu T; Zhao HY; Bian BL; Huang M; Bi HC
    J Ethnopharmacol; 2014 Oct; 156():175-81. PubMed ID: 25219605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
    Chun YJ; Kim MY; Guengerich FP
    Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.